Susan McElroy
Psychiatry · Mason, OHNPI 1841385986
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $29,484 of the $39,347 with a category attached, or 74.9%. It is spread thinly across 13 manufacturers, the largest accounting for just 23.5%. Reporting peaked in 2019 at $15,394 and has fallen 85.5% since, to $2,239 in 2025. Among psychiatry clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $915.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$9K
- Sunovion Pharmaceuticals Inc.$5K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$5K
- Shire North American Group Inc$4K
- Novo Nordisk AS$3K
- Mitsubishi Tanabe Pharma Development America, Inc.$3K
- plus $10K from 7 others
Across 138 payments — averaging $7461.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk$731K
- Jazz Pharmaceuticals Inc.$151K
- Neurocrine Biosciences, Inc.$95K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$39K
- AbbVie$9K
- Sunovion Pharmaceuticals Inc.$4K
- plus $806 from 1 others
What the payments were for
- Consulting fees$29,48475%
- Speaking & faculty fees$6,13216%
- Travel & lodging$2,7647%
- Food & beverage$8992%
- Education$670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 3 | $9,256 |
| Sunovion Pharmaceuticals Inc. | 15 | $5,428 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 9 | $5,105 |
| Shire North American Group Inc | 1 | $3,600 |
| Novo Nordisk AS | 3 | $3,200 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 1 | $2,500 |
| Axsome Therapeutics, Inc. | 3 | $2,239 |
| Boehringer Ingelheim | 1 | $2,225 |
| Neurocrine Biosciences, Inc. | 1 | $2,000 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $2,000 |
| Avanir Pharmaceuticals, Inc. | 2 | $1,700 |
| AbbVie | 2 | $62 |
| Novo Nordisk | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DASOTRALINE$4,998
- CAPLYTA$2,000
- SPRAVATO$1,181
- Auvelity$116
How this compares
$39,347 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Mason
- Danielle JohnsonMason$18K
- Henry NasrallahCincinnati$3.8M
- Fred RomeoColumbus$2.3M
- Amita PatelDayton$2.1M
- Pradeep ManudhaneCanton$1.5M
- Michael SaribalasColumbus$1.2M
- Kevin WareColumbus$1.1M
- Binit ShahCleveland$913K
- Paul KeckCincinnati$739K
- Ali MelhemSteubenville$681K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.